xanthenes has been researched along with Pulmonary Hypertension in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Liu, Y; Yan, D; Zhang, H; Zhang, Y; Zhao, L | 1 |
| Maron, BA | 1 |
| Akhter, SA; Archer, SL; Blaxall, BC; D'Souza, KM; Fang, YH; Parikh, KS; Paul, J; Piao, L; Pogoriler, J; Ryan, JJ; Theccanat, T; Toth, PT | 1 |
| Cong, H; Li, Z; Odajima, K; Ouda, H; Takemura, H; Wei, M; Zhang, Q; Zhao, S | 1 |
| Bryan, AC; Collins-Williams, C; Levison, H; Orange, RP; Reilly, BJ | 1 |
| Malta, Jde A | 1 |
1 review(s) available for xanthenes and Pulmonary Hypertension
| Article | Year |
|---|---|
Asthma: current concepts.
Topics: Adolescent; Albuterol; Asthma; Beclomethasone; Bronchodilator Agents; Carboxylic Acids; Child; Child, Preschool; Cromolyn Sodium; Cyclic AMP; Cyclic GMP; Humans; Hypertension, Pulmonary; Immunoglobulin E; Metaproterenol; Phenols; Prostaglandins; Pulmonary Atelectasis; Pulmonary Edema; Radiography; Respiratory Function Tests; Terbutaline; Tetrazoles; Xanthenes | 1974 |
5 other study(ies) available for xanthenes and Pulmonary Hypertension
| Article | Year |
|---|---|
Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Endothelium, Vascular; Enzyme Activators; Humans; Hypertension, Pulmonary; Imidazoles; Leucine; Lung; Male; Monocrotaline; Naphthalenes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Phosphorylation; Pulmonary Artery; Pyrans; Rats; Rats, Sprague-Dawley; Signal Transduction; Specific Pathogen-Free Organisms; Spiro Compounds; Xanthenes | 2017 |
Targeting neurohumoral signaling to treat pulmonary hypertension: the right ventricle coming into focus.
Topics: Animals; Female; G-Protein-Coupled Receptor Kinase 2; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Xanthenes | 2012 |
GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
Topics: Animals; Cardiotonic Agents; Cells, Cultured; Dobutamine; Dopamine; Down-Regulation; Female; G-Protein-Coupled Receptor Kinase 2; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Myocardial Contraction; Myocytes, Cardiac; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Signal Transduction; Xanthenes | 2012 |
High responsiveness of cytosolic free calcium concentration to angiotensin II in cultured pulmonary arterial myocytes from pulmonary hypertensive rats.
Topics: Angiotensin II; Aniline Compounds; Animals; Calcimycin; Calcium; Cells, Cultured; Cytosol; Fluorescent Dyes; Hypertension, Pulmonary; Muscle, Smooth, Vascular; Pulmonary Artery; Rats; Vasoconstrictor Agents; Xanthenes | 1997 |
[Use of hycanthone in schistosomiasis patients with pulmonary hypertension. Preliminary note].
Topics: Adolescent; Adult; Anthelmintics; Ethanol; Ethylamines; Evaluation Studies as Topic; Female; Heart; Humans; Hypertension, Pulmonary; Male; Schistosomiasis; Xanthenes | 1972 |